Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Skrit37on Nov 26, 2020 6:06pm
106 Views
Post# 31985904

RE:RE:RE:RE:RE:CC

RE:RE:RE:RE:RE:CCIll try and explain myself in an other way...sometimes i dont explain whats in my head to computer the same way haha


So Q1(jan1-march31),Q2(april1-june30),Q3(july1-sept30) have a 45 day grace period following the final day of the quarter to report finiancials to shareholders

any income "recieved" within each quarter has to be reported..
any income that has not been recieved within this quarter does not have to be reported until the following quarter

so for example if SZ tested for a nursing home on august 1st.....this revenue will not be realized if invoiced until/within 45 days later which falls within Q 4

therefore SZ will not have included this revenue in Q3 even though the revenue was recieved within the 45 days

IMO this is how understand it...

revenue recieved within the quarter is what we are shown...not revenue recieved after the Q's ending date..... even though the testing was done within the quarter

i hope this helps a bit more......im no accountant obviously....so if im wrong im all ears and will learn something new haha









Bullboard Posts